Loading
Latest filing published 24 Aug 2021 for SOL Global Investments Corp. (formerly Scythian Biosciences Corp.), €44k.
No signal scores available.
All filings by Andrew A. DeFrancesco on record concern SOL Global Investments Corp. (formerly Scythian Biosciences Corp.). We count 3 filings; the first trade dates from 8 September 2020 and the latest from 23 August 2021.
No open-market sale appears; the market trades are 1 purchase worth €44k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2021: 1 purchase and no sales on the market.
Most recently, on 24 August 2021, the filings show an open-market purchase worth €44k in SOL Global Investments Corp. (formerly Scythian Biosciences Corp.). Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations